Compare SPB & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPB | TNDM |
|---|---|---|
| Founded | 1906 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1994 | 2013 |
| Metric | SPB | TNDM |
|---|---|---|
| Price | $73.62 | $21.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 19 |
| Target Price | ★ $82.40 | $27.05 |
| AVG Volume (30 Days) | 320.7K | ★ 2.5M |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $3,802,100,000.00 | $1,014,736,000.00 |
| Revenue This Year | $1.78 | $8.01 |
| Revenue Next Year | $1.85 | $12.14 |
| P/E Ratio | $61.36 | ★ N/A |
| Revenue Growth | ★ 20.86 | 7.93 |
| 52 Week Low | $49.99 | $10.00 |
| 52 Week High | $80.42 | $29.65 |
| Indicator | SPB | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 47.70 |
| Support Level | $51.36 | $19.48 |
| Resistance Level | $80.42 | $21.89 |
| Average True Range (ATR) | 2.35 | 1.40 |
| MACD | -0.95 | -0.39 |
| Stochastic Oscillator | 3.36 | 14.77 |
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.